tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMRX Stock Latest News

Immuneering on track to dose first patient in pancreatic cancer trial in 2026
The FlyImmuneering on track to dose first patient in pancreatic cancer trial in 2026
2d ago
IMRX
Immuneering to be added to the Nasdaq Biotechnology Index
PremiumThe Fly
Immuneering to be added to the Nasdaq Biotechnology Index
4d ago
IMRX
Immuneering Corp. Shines in Positive Earnings Call
PremiumCompany Announcements
Immuneering Corp. Shines in Positive Earnings Call
1M ago
IMRX
Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating
PremiumRatings
Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating
1M ago
IMRX
Immuneering Corp. Reports Strong Q3 2025 Progress
PremiumCompany Announcements
Immuneering Corp. Reports Strong Q3 2025 Progress
1M ago
IMRX
Immuneering reports Q3 EPS (38c), consensus (39c)
PremiumThe FlyImmuneering reports Q3 EPS (38c), consensus (39c)
1M ago
IMRX
Immuneering expects cash to fund operations into 2029
Premium
The Fly
Immuneering expects cash to fund operations into 2029
1M ago
IMRX
IMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
IMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
IMRX
3 Best Stocks to Buy Now, 11/3/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 11/3/2025, According to Top Analysts
2M ago
CORZ
IMRX
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
2M ago
U
APP
Immuneering initiated with an Outperform at Leerink
PremiumThe Fly
Immuneering initiated with an Outperform at Leerink
2M ago
IMRX
Immuneering price target raised to $12 from $10 at Mizuho
PremiumThe Fly
Immuneering price target raised to $12 from $10 at Mizuho
2M ago
IMRX
Two new option listings and three option delistings on October 2nd
PremiumThe FlyTwo new option listings and three option delistings on October 2nd
3M ago
BBBY
COOP
Immuneering’s Promising Phase 2a Data and Safety Profile Drive Buy Rating
Premium
Ratings
Immuneering’s Promising Phase 2a Data and Safety Profile Drive Buy Rating
3M ago
IMRX
Immuneering Announces Public Offering to Raise $164.1M
Premium
Company Announcements
Immuneering Announces Public Offering to Raise $164.1M
3M ago
8K
IMRX
Immuneering price target raised to $30 from $21 at Oppenheimer
PremiumThe Fly
Immuneering price target raised to $30 from $21 at Oppenheimer
3M ago
IMRX
Immuneering 18.96M share Spot Secondary priced at $9.23
PremiumThe Fly
Immuneering 18.96M share Spot Secondary priced at $9.23
3M ago
IMRX
Promising Clinical Trial Results and Favorable Safety Profile Support Buy Rating for Immuneering
PremiumRatings
Promising Clinical Trial Results and Favorable Safety Profile Support Buy Rating for Immuneering
3M ago
IMRX
Immuneering Announces $25M Securities Purchase Agreement
PremiumCompany Announcements
Immuneering Announces $25M Securities Purchase Agreement
3M ago
8K
IMRX
Immuneering announces data from trial of atebimetinib combination
PremiumThe FlyImmuneering announces data from trial of atebimetinib combination
3M ago
IMRX
Immuneering announces Class A common stock offering, private placement
Premium
The Fly
Immuneering announces Class A common stock offering, private placement
3M ago
IMRX
Immuneering appoints Schall as Chairman of the Board
Premium
The Fly
Immuneering appoints Schall as Chairman of the Board
3M ago
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >